Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

225 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Docetaxel and high-dose epirubicin as neoadjuvant chemotherapy in locally advanced breast cancer.
Espinosa E, Morales S, Borrega P, Casas A, Madroñal C, Machengs I, Illarramendi JA, Lizón J, Moreno JA, Belón J, Janáriz J, de la Puente M, Checa T, Mel JR, González Barón M. Espinosa E, et al. Among authors: gonzalez baron m. Cancer Chemother Pharmacol. 2004 Dec;54(6):546-52. doi: 10.1007/s00280-004-0830-1. Epub 2004 Aug 17. Cancer Chemother Pharmacol. 2004. PMID: 15316749 Clinical Trial.
Combination of low-dose cisplatin and gemcitabine for treatment of elderly patients with advanced non-small-cell lung cancer.
Feliu J, Martín G, Madroñal C, Rodríguez-Jaráiz A, Castro J, Rodríguez A, Checa T, Bolaño M, Casado E, González-Barón M. Feliu J, et al. Among authors: gonzalez baron m. Cancer Chemother Pharmacol. 2003 Sep;52(3):247-52. doi: 10.1007/s00280-003-0638-4. Epub 2003 May 29. Cancer Chemother Pharmacol. 2003. PMID: 12783203 Clinical Trial.
Docetaxel and mitomycin as second-line treatment in advanced non-small cell lung cancer.
Feliu J, Martín G, Castro J, Sundlov A, Rodriguez-Jaráiz A, Casado E, Lomas M, Madroñal C, Galán A, Belda C, Gonzalez-Barón M. Feliu J, et al. Among authors: gonzalez baron m. Cancer Chemother Pharmacol. 2006 Oct;58(4):527-31. doi: 10.1007/s00280-006-0198-5. Epub 2006 Mar 23. Cancer Chemother Pharmacol. 2006. PMID: 16555090 Clinical Trial.
Treatment of metastatic malignant melanoma with cisplatin plus tamoxifen.
Feliu J, González Barón M, Chacón JI, Espinosa E, Garrido P, Castro J, Escobar Y, Colmenarejo A, Jara C, García Girón C, Espinosa J, Ordóñez A. Feliu J, et al. Among authors: gonzalez baron m. Cancer Chemother Pharmacol. 1996;38(2):191-4. doi: 10.1007/s002800050469. Cancer Chemother Pharmacol. 1996. PMID: 8616911 Clinical Trial.
Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group.
Feliu J, González Barón M, García-Girón C, Espinosa E, García-Alfonso P, Belón J, Blanco E, Garrido P, Ordónez A, Gómez-Navarro J, Zamora P. Feliu J, et al. Among authors: gonzalez baron m. Cancer. 1996 Jul 15;78(2):211-6. doi: 10.1002/(SICI)1097-0142(19960715)78:2<211::AID-CNCR4>3.0.CO;2-O. Cancer. 1996. PMID: 8673994 Clinical Trial.
Phase II trial of gemcitabine and UFT modulated by leucovorin in patients with advanced pancreatic carcinoma. The ONCOPAZ Cooperative Group.
Feliu J, López Alvarez MP, Jaraiz MA, Constenla M, Vicent JM, Belón J, López Gómez L, de Castro J, Dorta J, González Barón M. Feliu J, et al. Among authors: gonzalez baron m. Cancer. 2000 Oct 15;89(8):1706-13. doi: 10.1002/1097-0142(20001015)89:8<1706::aid-cncr9>3.0.co;2-i. Cancer. 2000. PMID: 11042564 Clinical Trial.
Sequential therapy in advanced non-small-cell lung cancer with weekly paclitaxel followed by cisplatin-gemcitabine-vinorelbine. A phase II study.
Feliu J, Martin G, Lizón J, Chacón JI, Dorta J, de Castro J, Rodríguez A, Sánchez Heras B, Torrego JC, Espinosa E, González Barón M; Oncopaz Cooperative Group, Spain. Feliu J, et al. Among authors: gonzalez baron m. Ann Oncol. 2001 Oct;12(10):1369-74. doi: 10.1023/a:1012552525667. Ann Oncol. 2001. PMID: 11762806 Free article. Clinical Trial.
225 results